Rates of Tobacco Use Disorder, Pharmacologic Treatment, and Associated Mental Health Disorders in a Medicaid Claim Review Among Youth in Indiana, USA
Purpose This study delineates a number of Medicaid youth with tobacco use disorder (TUD), prescribing habits for treatment, and associated externalizing disorders. Methods Youth Medicaid claims from 2007-2017 processed in a large Midwestern city were analyzed for a diagnosis of TUD, related pharmaco...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-08-01
|
Series: | Tobacco Use Insights |
Online Access: | https://doi.org/10.1177/1179173X221119133 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1825206721420722176 |
---|---|
author | Corey McBrayer DO, FAAP Fangqian Ouyang MS Zachary Adams PhD Leslie Hulvershorn MD Matthew C. Aalsma PhD |
author_facet | Corey McBrayer DO, FAAP Fangqian Ouyang MS Zachary Adams PhD Leslie Hulvershorn MD Matthew C. Aalsma PhD |
author_sort | Corey McBrayer DO, FAAP |
collection | DOAJ |
description | Purpose This study delineates a number of Medicaid youth with tobacco use disorder (TUD), prescribing habits for treatment, and associated externalizing disorders. Methods Youth Medicaid claims from 2007-2017 processed in a large Midwestern city were analyzed for a diagnosis of TUD, related pharmacotherapy, and externalizing mental health and substance use disorders. Results Claims connected 6541 patients with 42 890 visits. Mean age was 16.4 with 40% female. 1232 of the 6541 charts contained a TUD diagnosis equating to 1848 visits. A comorbid diagnosis of ADHD, cannabis use, and conduct disorder were more common in males (3.9% vs 1.3% in females; 3.4% vs .8%; and 2.8% vs .8%; P < .05). 808 scripts were provided to 152 of the 1232 youths, with 4.7% of those scripts a nicotine replacement product. Conclusions Pharmacotherapy is underutilized in this Medicaid claims data set. Certain externalizing factors were associated with males with TUD more than females. |
format | Article |
id | doaj-art-740147a6d8b444b58cc3bfa3b0f7c693 |
institution | Kabale University |
issn | 1179-173X |
language | English |
publishDate | 2022-08-01 |
publisher | SAGE Publishing |
record_format | Article |
series | Tobacco Use Insights |
spelling | doaj-art-740147a6d8b444b58cc3bfa3b0f7c6932025-02-07T06:03:21ZengSAGE PublishingTobacco Use Insights1179-173X2022-08-011510.1177/1179173X221119133Rates of Tobacco Use Disorder, Pharmacologic Treatment, and Associated Mental Health Disorders in a Medicaid Claim Review Among Youth in Indiana, USACorey McBrayer DO, FAAPFangqian Ouyang MSZachary Adams PhDLeslie Hulvershorn MDMatthew C. Aalsma PhDPurpose This study delineates a number of Medicaid youth with tobacco use disorder (TUD), prescribing habits for treatment, and associated externalizing disorders. Methods Youth Medicaid claims from 2007-2017 processed in a large Midwestern city were analyzed for a diagnosis of TUD, related pharmacotherapy, and externalizing mental health and substance use disorders. Results Claims connected 6541 patients with 42 890 visits. Mean age was 16.4 with 40% female. 1232 of the 6541 charts contained a TUD diagnosis equating to 1848 visits. A comorbid diagnosis of ADHD, cannabis use, and conduct disorder were more common in males (3.9% vs 1.3% in females; 3.4% vs .8%; and 2.8% vs .8%; P < .05). 808 scripts were provided to 152 of the 1232 youths, with 4.7% of those scripts a nicotine replacement product. Conclusions Pharmacotherapy is underutilized in this Medicaid claims data set. Certain externalizing factors were associated with males with TUD more than females.https://doi.org/10.1177/1179173X221119133 |
spellingShingle | Corey McBrayer DO, FAAP Fangqian Ouyang MS Zachary Adams PhD Leslie Hulvershorn MD Matthew C. Aalsma PhD Rates of Tobacco Use Disorder, Pharmacologic Treatment, and Associated Mental Health Disorders in a Medicaid Claim Review Among Youth in Indiana, USA Tobacco Use Insights |
title | Rates of Tobacco Use Disorder, Pharmacologic Treatment, and Associated Mental Health Disorders in a Medicaid Claim Review Among Youth in Indiana, USA |
title_full | Rates of Tobacco Use Disorder, Pharmacologic Treatment, and Associated Mental Health Disorders in a Medicaid Claim Review Among Youth in Indiana, USA |
title_fullStr | Rates of Tobacco Use Disorder, Pharmacologic Treatment, and Associated Mental Health Disorders in a Medicaid Claim Review Among Youth in Indiana, USA |
title_full_unstemmed | Rates of Tobacco Use Disorder, Pharmacologic Treatment, and Associated Mental Health Disorders in a Medicaid Claim Review Among Youth in Indiana, USA |
title_short | Rates of Tobacco Use Disorder, Pharmacologic Treatment, and Associated Mental Health Disorders in a Medicaid Claim Review Among Youth in Indiana, USA |
title_sort | rates of tobacco use disorder pharmacologic treatment and associated mental health disorders in a medicaid claim review among youth in indiana usa |
url | https://doi.org/10.1177/1179173X221119133 |
work_keys_str_mv | AT coreymcbrayerdofaap ratesoftobaccousedisorderpharmacologictreatmentandassociatedmentalhealthdisordersinamedicaidclaimreviewamongyouthinindianausa AT fangqianouyangms ratesoftobaccousedisorderpharmacologictreatmentandassociatedmentalhealthdisordersinamedicaidclaimreviewamongyouthinindianausa AT zacharyadamsphd ratesoftobaccousedisorderpharmacologictreatmentandassociatedmentalhealthdisordersinamedicaidclaimreviewamongyouthinindianausa AT lesliehulvershornmd ratesoftobaccousedisorderpharmacologictreatmentandassociatedmentalhealthdisordersinamedicaidclaimreviewamongyouthinindianausa AT matthewcaalsmaphd ratesoftobaccousedisorderpharmacologictreatmentandassociatedmentalhealthdisordersinamedicaidclaimreviewamongyouthinindianausa |